885
Participants
Start Date
July 6, 2021
Primary Completion Date
September 27, 2022
Study Completion Date
September 27, 2022
mRNA-1010
Sterile liquid for injection
Placebo
0.9% sodium chloride solution for injection
Active Comparator
0.5 milliliter (mL) intramuscular (IM) injection
Meridian Clinical Research (Endwell-New York) - Platinum - PPDS, Endwell
Trial Management Associates LLC - ERN - PPDS, Wilmington
Lucas Research, Morehead City
Keystone VitaLink Research - Greenville - PPDS, Greenville
Meridian Clinical Research (Savannah Georgia) - Platinum - PPDS, Savannah
Meridian Clinical Research - Cincinnati - Platinum - PPDS, Cincinnati
Meridian Clinical Research - Cincinnati - Platinum - PPDS, Cincinnati
Johnson County Clin-Trials, Lenexa
Meridian Clinical Research, LLC (Lincoln Nebraska), Lincoln
Meridian Clinical Research (Grand Island), Grand Island
Meridian Clinical Research - Baton Rouge, Baton Rouge
Research Your Health - ERN - PPDS, Plano
PanAmerican Clinical Research LLC, Brownsville
South Ogden Family Medicine/Ogden Clinic - CCT, South Ogden
Cognitive Clinical Trials - Phoenix, Phoenix
Alliance for Multispecialty Research, LLC - Phoenix, Tempe
Benchmark Research - Colton, CA, Colton
Research Centers of America - ERGG - PPDS, Hollywood
Meridian Clinical Research, Sioux City
Meridian Clinical Research, Rockville
Meridian Clinical Research, Omaha
ModernaTX, Inc.
INDUSTRY